+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Aratana Therapeutics Inc (PETX) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Aratana Therapeutics Inc (Aratana) is a pet therapeutics company that licenses, develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. The company’s pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim for the treatment serious conditions in pets. It offers products such candidates include GALLIPRANT (AT-001), for the treatment of osteoarthritis pain and inflammation; ENTYCE (AT-002), for appetite stimulation and NOCITA (AT-003), for post-operative pain in dogs. Aratana provides its therapeutic products such as entice, nocita and galliprant. It offers products for the therapeutic areas of osteoarthritis pain, post-operative pain, inappetence, cancer, viral diseases, allergy and among others. The company has its presence in Leuven, Belgium; Boston, Massachusetts and San Deigo, California in the US. Aratana is headquartered in Leawood, Kansas, the US.

Aratana Therapeutics Inc Key Recent Developments

Aug 03, 2017: Aratana Therapeutics Reports Second Quarter 2017 Financial Results

This comprehensive SWOT profile of Aratana Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aratana Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Aratana Therapeutics Inc - Key Information
  • Aratana Therapeutics Inc - Overview
  • Aratana Therapeutics Inc - Key Employees
  • Aratana Therapeutics Inc - Key Employee Biographies
  • Aratana Therapeutics Inc - Key Operational Heads
  • Aratana Therapeutics Inc - Major Products and Services
  • Aratana Therapeutics Inc - History
  • Aratana Therapeutics Inc - Company Statement
  • Aratana Therapeutics Inc - Locations And Subsidiaries
  • Aratana Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Aratana Therapeutics Inc - Business Description
  • Aratana Therapeutics Inc - Corporate Strategy
  • Aratana Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Aratana Therapeutics Inc - Strengths
  • Aratana Therapeutics Inc - Weaknesses
  • Aratana Therapeutics Inc - Opportunities
  • Aratana Therapeutics Inc - Threats
  • Aratana Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Aratana Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Aratana Therapeutics Inc, Key Information
  • Aratana Therapeutics Inc, Key Ratios
  • Aratana Therapeutics Inc, Share Data
  • Aratana Therapeutics Inc, Major Products and Services
  • Aratana Therapeutics Inc, History
  • Aratana Therapeutics Inc, Key Employees
  • Aratana Therapeutics Inc, Key Employee Biographies
  • Aratana Therapeutics Inc, Key Operational Heads
  • Aratana Therapeutics Inc, Other Locations
  • Aratana Therapeutics Inc, Subsidiaries
  • Aratana Therapeutics Inc, Key Manufacturing facilities
  • Aratana Therapeutics Inc, Key Competitors
  • Aratana Therapeutics Inc, SWOT Analysis
  • Aratana Therapeutics Inc, Ratios based on current share price
  • Aratana Therapeutics Inc, Annual Ratios
  • Aratana Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Aratana Therapeutics Inc, Performance Chart
  • Aratana Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3


Order Online - visit: https://www.researchandmarkets.com/reports/4284940